Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of direct-to-consumer predictive genomic testing on risk perception and worry among patients receiving routine care in a preventive health clinic.

Mayo Clinic proceedings - 1 Oct 2011

James Katherine M, Cowl Clayton T, Tilburt Jon C, Sinicrope Pamela S, Robinson Marguerite E, Frimannsdottir Katrin R, Tiedje Kristina, Koenig Barbara A

Abstract excerpt

OBJECTIVE: To assess the impact of direct-to-consumer (DTC) predictive genomic risk information on perceived risk and worry in the context of routine clinical care. PATIENTS AND METHODS: Patients attending a preventive medicine clinic between June 1 and December 18, 2009, were randomly assigned to receive either genomic risk information from a DTC product plus usual care (n=74) or usual care alone (n=76). At...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anxiety
Share to Aortic Aneurysm, Abdominal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Decision Making

Share to Genetic Counseling

Share to Graves Disease

Share to Osteoarthritis

Share to Precision Medicine

Share to Qualitative Research

Source

Open in PubMed Open full text

Identifiers

PMID: 21964170
DOI: 10.4065/mcp.2011.0190
PMCID: PMC3184022

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of direct-to-consumer predictive genomic testing on risk perception and worry among patients receiving routine care in a preventive health clinic.PMID 21964170Read ↗

Consumer perceptions of direct-to-consumer personalized genomic risk assessments.Semantic proximity Read ↗

The impact of direct-to-consumer personal genomic testing on perceived risk of breast, prostate, colorectal, and lung cancer: findings from the PGen study.Semantic proximity Read ↗

The effect of disease risk probability and disease type on interest in clinic-based versus direct-to-consumer genetic testing services.Semantic proximity Read ↗

Direct-to-Consumer Personal Genome Testing and Cancer Risk PredictionSemantic proximity Read ↗

Impact of direct-to-consumer genomic testing at long term follow-up.Semantic proximity Read ↗

Clinical implications of direct-to-consumer genetic testing for cardiovascular disease risk.Semantic proximity Read ↗

Effect of direct-to-consumer genomewide profiling to assess disease risk.Semantic proximity Read ↗

Direct-to-consumer pharmacogenomic testing is associated with increased physician utilisation.Semantic proximity Read ↗

State of play in direct-to-consumer genetic testing for lifestyle-related diseases: market, marketing content, user experiences and regulation.Semantic proximity Read ↗

Effectiveness of receiving cardiovascular disease genetic risk information on health behaviors, psychological responses, and associated risk factor modification in individuals: a systematic review protocol.Semantic proximity Read ↗

Direct‐to‐consumer genetic testing: good, bad or benign?Semantic proximity Read ↗

Effect of Direct‐to‐Consumer Genetic Tests on Health Behaviour and Anxiety: A Survey of Consumers and Potential ConsumersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.